Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses WDAY Q1 2026 Earnings EPS Beats Estimates by 40 Shares Rise PROV Q1 2026 Earnings EPS Misses Estimates Despite Modest Share Price Gain EFSCP Q1 2026 Earnings EPS Falls Short of Estimates Stock Edges Higher CMI Q1 2026 Earnings EPS Beat by 897 on Strong Operational Performance Solid Power Inc SLDP Shares Surge 4 as Stock Tests Key Resistance Level Plum Acquisition Corp IV Unit PLMKU Holds Steady at 1088 as Market Awaits Catalyst Swvl Holdings Corp SWVL Retreats 1066 as Key Support Levels Are Tested Agriculture Natural Solutions Acquisition Warrant ANSCW Holds Flat at 023 Amid Low Volume WHLR Q2 2024 Earnings EPS of 365 Strengthens as Stock Declines 136